IL6 Goat Polyclonal Antibody

CAT#: TA328216

Anti-Human IL-6 Goat Polyclonal Antibody

Product Images

To detect Human IL-6 by sandwich ELISA (using 100 ul/well antibody solution) a concentration of 0.5 - 2.0 ug/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human IL-6 (TA328215) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human IL-6.

• 

  To detect Human IL-6 by sandwich ELISA (using 100 ul/well antibody solution) a concentration of 0.5 - 2.0 ug/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with Biotinylated Anti-Human IL-6 (TA328215) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human IL-6.

Specifications

Product Data

• Applications: ELISA, WB
• Recommended Dilution: WB: 0.1-0.2ug/mL, ELISA: 0.25-2ug/mL, IHC: 0.25ug/mL - 1mg/mL
• Reactivities: Human
• Host: Goat
• Isotype: IgG
• Clonality: Polyclonal
• Immunogen: E.coli derived Recombinant Human IL-6
• Formulation: A sterile filtered antibody solution was lyophilized from PBS, pH 7.2.
• Purification: Produced from sera of goats pre-immunized with highly pure recombinant Human IL-6. Anti-Human IL-6 specific antibody was purified by affinity chromatography employing immobilized Human IL-6 matrix.
• Conjugation: Unconjugated
• Storage: Store at -20°C as received.
• Stability: Stable for 12 months from date of receipt.
• Gene Name: interleukin 6
• Database Link:
  NP_000591
  Entrez Gene 3569 Human
  UniProt ID P05231
• Synonyms: BSF-2; BSF2; CDF; HGF; HSF; IFN-beta-2; IFNB2; IL-6
• Note: Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity of Human IL-6 (5 ng/ml), a concentration of 0.05 - 0.08 <=ug/ml of this antibody is required.

Reference Data

• Protein Families: Druggable Genome, Secreted Protein
• Protein Pathways: Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Graft-versus-host disease, Hematopoietic cell lineage, Hypertrophic cardiomyopathy (HCM), Jak-STAT signaling pathway, NOD-like receptor signaling pathway, Pathways in cancer, Prion diseases, Toll-like receptor signaling pathway